Fmoc-alpha-Me-D-Lys(Boc)-OH

Fmoc-alpha-Me-D-Lys(Boc)-OH is an Fmoc-protected, side-chain-protected lysine derivative bearing an alpha-methyl substituent and a D-configuration at the amino acid stereocenter. The molecule contains a carbamate-protected epsilon-amine (Boc on the lysine side chain) and an N-(9-fluorenylmethoxycarbonyl) protecting group on the alpha-amine, yielding a protected amino acid building block compatible with stepwise peptide assembly. The alpha-methyl group increases steric differentiation around the backbone, which can influence coupling kinetics, conformational preferences, and stereochemical outcomes in downstream transformations. The protected functional groups and the chiral center make the compound a practical intermediate for controlled amino acid derivatization, peptide coupling chemistry, and stereodefined incorporation of D-amino acid motifs into peptide and peptidomimetic scaffolds.

1. Peptide Synthesis

Fmoc-alpha-Me-D-Lys(Boc)-OH is used in peptide synthesis workflows where orthogonal protection allows sequential N-deprotection and side-chain handling. The Fmoc group supports base-mediated removal to generate a reactive alpha-amino function for peptide bond formation, while the Boc-protected lysine side-chain amine remains masked during early coupling steps. The D-lysine stereochemistry and alpha-methyl substitution enable construction of stereochemically defined peptide segments that can be used to probe backbone effects on folding, proteolytic stability, or receptor recognition. Downstream peptide assembly can incorporate this residue into longer sequences for research-grade peptide building block preparation and for generating stereodefined analog libraries.

2. Side-Chain Functionalization

Fmoc-alpha-Me-D-Lys(Boc)-OH serves as a protected precursor for lysine side-chain modification strategies in chemical biology and materials-oriented synthesis. The Boc-protected epsilon-amine can be selectively deprotected under conditions compatible with the Fmoc strategy, enabling subsequent formation of urea, amide, sulfonamide, or carbamate linkages for installing functional handles such as reactive electrophiles, affinity tags, or solubilizing groups. The alpha-methyl and D-configuration can modulate local sterics and hydrogen-bonding patterns around the lysine residue, which may affect conjugation efficiency and the stability of the resulting derivatives. The resulting functionalized amino acid or short peptide fragments can then be used for targeted molecular modification and downstream scaffold elaboration.

3. Drug Discovery SAR Studies

Fmoc-alpha-Me-D-Lys(Boc)-OH is applied in structure-activity relationship studies where incorporation of D-lysine and alpha-methylated backbones helps define how stereochemistry and steric bulk influence bioactive conformations. The protected amino acid form supports rapid generation of peptide analogs by standard peptide coupling chemistry, enabling systematic variation of side-chain chemistry while maintaining a consistent stereochemical framework. The orthogonal protection pattern (Fmoc on the alpha-amine and Boc on the epsilon-amine) facilitates controlled derivatization of the lysine functionality without premature cross-reactivity during scaffold assembly. Peptidomimetic and peptide-like libraries prepared from this residue can be used as chemically defined inputs for SAR mapping and mechanistic exploration in medicinal chemistry programs.

4. Bioconjugation Chemistry

Fmoc-alpha-Me-D-Lys(Boc)-OH is suitable for bioconjugation development where lysine-derived amine reactivity is required after orthogonal deprotection. The Boc-protected epsilon-amine provides a protected site that can be converted into conjugation-ready amide or linker-bearing derivatives, while the Fmoc strategy supports controlled exposure of the alpha-amino terminus when building peptide-based conjugates. The D-configuration and alpha-methyl substitution can help tune the conformational presentation of the lysine side chain within the conjugate, which may influence binding interactions and stability of the final labeled or functional biomolecule. Resulting conjugation intermediates are applicable to preparing research reagents such as peptide conjugates, labeled probes, and linker-functional fragments for biochemical assays.

5. Pharmaceutical Manufacturing

Fmoc-alpha-Me-D-Lys(Boc)-OH can be integrated into pharmaceutical manufacturing and fine-chemical production routes that require stereodefined, protected amino acid intermediates for peptide-derived materials. The Fmoc/Boc orthogonal protection scheme supports process-compatible protection and deprotection sequences during stepwise assembly of peptide intermediates, reducing the likelihood of undesired side reactions from unmasked amines. The chiral alpha-methylated D-lysine backbone provides a controlled stereocenter for producing consistent peptide segments used in manufacturing of peptide-based drug candidates, reference standards, or process intermediates. The compound's protected functional groups also support downstream conversion into activated coupling forms or further derivatized residues while maintaining defined stereochemistry for reliable batch-to-batch consistency in applied peptide synthesis.

1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Cationic cell-penetrating peptides are potent furin inhibitors